Corindus Vascular Robotics Stock Price, News & Analysis (NYSEAMERICAN:CVRS)

Corindus Vascular Robotics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CVRS."

Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) announced its quarterly earnings data on Thursday, August, 8th. The medical equipment provider reported ($0.06) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.05) by $0.01. The medical equipment provider had revenue of $4.58 million for the quarter, compared to analysts' expectations of $4.10 million. View Corindus Vascular Robotics' Earnings History.

Corindus Vascular Robotics is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for Corindus Vascular Robotics.

1 equities research analysts have issued 1-year price objectives for Corindus Vascular Robotics' shares. Their forecasts range from $4.28 to $4.28. On average, they expect Corindus Vascular Robotics' share price to reach $4.28 in the next twelve months. View Analyst Price Targets for Corindus Vascular Robotics.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Corindus Vascular Robotics in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Corindus Vascular Robotics.

Headlines about CVRS stock have trended somewhat positive this week, InfoTrie reports. The research firm ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Corindus Vascular Robotics earned a media sentiment score of 1.8 on InfoTrie's scale. They also assigned media stories about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Corindus Vascular Robotics.

Corindus Vascular Robotics saw a increase in short interest during the month of September. As of September 30th, there was short interest totalling 9,420,000 shares, an increase of 7.2% from the August 30th total of 8,790,000 shares. Based on an average daily volume of 3,300,000 shares, the short-interest ratio is currently 2.9 days. Currently, 7.4% of the shares of the company are sold short. View Corindus Vascular Robotics' Current Options Chain.

Some companies that are related to Corindus Vascular Robotics include Consort Medical (CSRT), Ekf Diagnostics (EKF), Immunodiagnostic Systems (IDH), Theralase Technologies (TLT), Intelligent Ultrasound Group (MED), LiDCO Group (LID), Deltex Medical Group (DEMG), Zecotek Photonics (ZMS), InspireMD (NSPR), Lucid (LCDX), MCP Income Opp Trust Ordinary Units FP (MOT) and Verisante Technology (VRS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Corindus Vascular Robotics investors own include Amarin (AMRN), TransEnterix (TRXC), Micron Technology (MU), Advanced Micro Devices (AMD), Alibaba Group (BABA), Helios and Matheson Analytics (HMNY), NVIDIA (NVDA), TherapeuticsMD (TXMD), Viking Therapeutics (VKTX) and Exelixis (EXEL).

Corindus Vascular Robotics' stock is owned by many different of institutional and retail investors. Top institutional investors include Havens Advisors LLC (0.16%) and Syquant Capital Sas (0.05%). Company insiders that own Corindus Vascular Robotics stock include Hudson Executive Capital Lp and Louis A Cannon. View Institutional Ownership Trends for Corindus Vascular Robotics.

CVRS stock was acquired by a variety of institutional investors in the last quarter, including Havens Advisors LLC and Syquant Capital Sas. Company insiders that have bought Corindus Vascular Robotics stock in the last two years include Hudson Executive Capital Lp and Louis A Cannon. View Insider Buying and Selling for Corindus Vascular Robotics.

Shares of CVRS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CVRS stock can currently be purchased for approximately $4.28.

Corindus Vascular Robotics has a market capitalization of $893.17 million. Corindus Vascular Robotics employs 90 workers across the globe.View Additional Information About Corindus Vascular Robotics.

The official website for Corindus Vascular Robotics is http://www.corindus.com/.

Corindus Vascular Robotics' mailing address is 309 Waverley Oaks Rd Ste 105, WALTHAM, MA 02452-8451, United States. The medical equipment provider can be reached via phone at +1-508-6533335.